Seragon completa el estudio preclínico del candidato a intervención contra el envejecimiento SRN-901

Seragon Biosciences Israel Algeria Bahrain Egypt Iran Iraq Jordan Kuwait Lebanon Libya Morocco Oman Qatar Saudi Arabia Syria Tunisia United Arab Emirates Yemen Angola Botswana Ethiopia Gambia Ghana Guinea-Bissau Kenya Lesotho Liberia Malawi Maldives Mozambique Namibia Nigeria Sierra Leone Somalia South Africa Swaziland Tanzania Uganda Zambia Zimbabwe California

View original content:https://www.prnewswire.com/news-releases/seragon-completa-el-estudio-preclinico-del-candidato-a-intervencion-contra-el-envejecimiento-srn-901-302137969.html

@ prnewswire.co.uk